Country Report

Cough, Cold and Allergy (Hay Fever) Remedies in

Cough, Cold and Allergy (Hay Fever) Remedies in France

Oct 2020

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

2020 IMPACT

Supervision of the distribution of vasoconstrictors and distrust of anti-cough medicines leads to a decline in value growth for 2020

Cough, cold and allergy (hay fever) remedies is set to record a decline in growth in 2020, despite the outbreak of COVID-19. This result is due to a general mistrust around anti-cough medicines, as well as a change in the distribution of vasoconstrictors.

Antihistamines/allergy remedies (systemic) drive growth as the early Spring has consumers reaching for solutions to hay fever and pollen-related allergies

Antihistamines/allergy remedies (systemic) is expected to record the highest growth in 2020, being the only area, alongside medicated confectionery, to have a positive performance during the year. During sunny days, the risk of pollen-related allergies increases, and taking antihistamines is common in France, to manage symptoms of hay fever or allergic rhinitis.

Solinest continues to grow through the positive performance of Ricola, while Reckitt Benckiser is set to lose share

Solinest is set to continue leading the cough, cold and allergy (hay fever) remedies landscape in 2020, with the Ricola medicated confectionery brand. Sales and share growth are both expected to increase, helped by the introduction of two new variants over the review period: Honey Sage and Echinacea Honey Lemon.

Files are delivered directly into your account within a few minutes of purchase.

Samples

Cough, Cold and Allergy Sample Report Cough, Cold and Allergy Sample Data

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Cough, Cold and Allergy (Hay Fever) Remedies industry in France with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in France, our research will save you time and money while empowering you to make informed, profitable decisions.

The Cough, Cold and Allergy (Hay Fever) Remedies in France market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Cough, Cold and Allergy (Hay Fever) Remedies in France?
What are the major brands in France?
What is the impact of influenza vaccinations on the sales of cough and cold products?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Want to find out more about this report?

Request more information

Cough, Cold and Allergy (Hay Fever) Remedies in France - Category analysis

KEY DATA FINDINGS

2020 IMPACT

Supervision of the distribution of vasoconstrictors and distrust of anti-cough medicines leads to a decline in value growth for 2020

Antihistamines/allergy remedies (systemic) drive growth as the early Spring has consumers reaching for solutions to hay fever and pollen-related allergies

Solinest continues to grow through the positive performance of Ricola, while Reckitt Benckiser is set to lose share

RECOVERY AND OPPORTUNITIES

Growth continues to record a decline over the forecast period, as antihistamines/allergy remedies (systemic) remain the key driver of growth

A move to behind-the-counter impacts growth over the forecast period, while Strepfen lozenges become prescription only

The growing mistrust of cold products increases consumers interest in natural alternatives across the forecast period

CATEGORY DATA

Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2015-2020
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2015-2020
Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2016-2020
Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2020
Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2020-2025
Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2020-2025

Consumer Health in France - Industry Overview

EXECUTIVE SUMMARY

COVID-19 impact on consumer health

COVID-19 country impact

Company response

Retailing shift

What next for consumer health?

MARKET INDICATORS

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
Table 8 Life Expectancy at Birth 2015-2020

MARKET DATA

Table 9 Sales of Consumer Health by Category: Value 2015-2020
Table 10 Sales of Consumer Health by Category: % Value Growth 2015-2020
Table 11 NBO Company Shares of Consumer Health: % Value 2016-2020
Table 12 LBN Brand Shares of Consumer Health: % Value 2017-2020
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2015-2020
Table 14 Distribution of Consumer Health by Format: % Value 2015-2020
Table 15 Distribution of Consumer Health by Format and Category: % Value 2020
Table 16 Forecast Sales of Consumer Health by Category: Value 2020-2025
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

Summary 1 OTC: Switches 2019-2020

GLOBAL MACROECONOMIC ENVIRONMENT

GLOBAL INDUSTRY ENVIRONMENT

DISCLAIMER

DEFINITIONS

SOURCES

Summary 2 Research Sources

Why buy this report?

Want to find out more about this report?

Request more information

Megatrends

Country Report

Cough, Cold and Allergy (Hay Fever) Remedies in France

New Report Guarantee

Executive Summary

New Report Guarantee

2020 IMPACT

Supervision of the distribution of vasoconstrictors and distrust of anti-cough medicines leads to a decline in value growth for 2020

Antihistamines/allergy remedies (systemic) drive growth as the early Spring has consumers reaching for solutions to hay fever and pollen-related allergies

Solinest continues to grow through the positive performance of Ricola, while Reckitt Benckiser is set to lose share

Samples

Overview

Why buy this report?

Samples (FAQs about samples):

Want to find out more about this report?

Table of Contents

Cough, Cold and Allergy (Hay Fever) Remedies in France - Category analysis

KEY DATA FINDINGS

2020 IMPACT

Supervision of the distribution of vasoconstrictors and distrust of anti-cough medicines leads to a decline in value growth for 2020

Antihistamines/allergy remedies (systemic) drive growth as the early Spring has consumers reaching for solutions to hay fever and pollen-related allergies

Solinest continues to grow through the positive performance of Ricola, while Reckitt Benckiser is set to lose share

RECOVERY AND OPPORTUNITIES

Growth continues to record a decline over the forecast period, as antihistamines/allergy remedies (systemic) remain the key driver of growth

A move to behind-the-counter impacts growth over the forecast period, while Strepfen lozenges become prescription only

The growing mistrust of cold products increases consumers interest in natural alternatives across the forecast period

CATEGORY DATA

Consumer Health in France - Industry Overview

EXECUTIVE SUMMARY

COVID-19 impact on consumer health

COVID-19 country impact

Company response

Retailing shift

What next for consumer health?

MARKET INDICATORS

MARKET DATA

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

GLOBAL MACROECONOMIC ENVIRONMENT

GLOBAL INDUSTRY ENVIRONMENT

DISCLAIMER

DEFINITIONS

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports